<DOC>
	<DOCNO>NCT00682110</DOCNO>
	<brief_summary>The purpose study determine less invasive monitor reliable measure heart function patient undergo liver transplantation invasive pulmonary artery .</brief_summary>
	<brief_title>Hemodynamic Measurements During Liver Transplantation</brief_title>
	<detailed_description>Pulmonary artery catheter ( PAC ) consider gold standard monitor heart function orthotopic liver transplantation ( OLT ) . Placement PAC invasive ( pass thorough heart chamber pulmonary artery ) benefit outcomes proven . This study compare two new FDA approve much less invasive device PAC . The two new device assess heart function base either peripheral arterial waveform alone ( Vigileo , Edwards Lifesciences ) combination peripheral arterial waveform chemical indicator dilution ( LiDCO , Cambridge , UK ) .</detailed_description>
	<criteria>Patients 18 year age Scheduled liver transplantation Patient undergo vascular surgery invasive arterial pressure indicate ( control subject ) We exclude patient take lithium base medication Patients weigh less 40 kg ; AND Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>End-stage liver disease</keyword>
	<keyword>Hemodynamic measurement</keyword>
	<keyword>Hyperdynamic circulation</keyword>
	<keyword>Pulmonary artery catheter</keyword>
	<keyword>Cardiac output</keyword>
</DOC>